Non-Invasive Tear Break-Up Time (NIBUT): Measurement and Management
NIBUT is measured by observing the tear film through specialized instruments that project luminous patterns (mires) onto the cornea, with the examiner timing how long it takes for the first break or distortion to appear in the reflected pattern—no fluorescein dye is required.
How NIBUT is Measured
NIBUT assessment involves non-invasive observation of tear film stability without disrupting the ocular surface with dye or anesthetic drops. The technique uses instruments that project patterns onto the tear film:
Measurement Technique
- Instruments available: Multiple devices can measure NIBUT including the Tearscope Plus, Keratograph 5M, topography-based systems (Medmont E300, Sirius), and handheld lipid layer examination instruments 1, 2, 3
- Procedure: The patient blinks normally, then keeps eyes open while the examiner observes the reflected mire pattern and times until the first break or distortion appears in the tear film
- Timing: Record both the first break-up time (NIBUT-f) and can calculate an average of multiple measurements (NIBUT-av) 4
- Number of measurements: Perform three consecutive measurements and use the mean value for clinical decision-making 2, 5
Key Technical Points
The measurement should be performed before any drops are instilled in the eye, as this is a truly non-invasive test 6. Different instruments have varying mire spacing, though this appears less critical than previously thought 7. Both subjective (examiner-observed) and objective (automated) measurements show reasonable agreement 3.
Diagnostic Thresholds
The optimal cut-off value for diagnosing dry eye disease is 10-12 seconds, with values below this indicating tear film instability:
- NIBUT < 10 seconds: Suggests abnormal tear film stability and potential dry eye disease 6, 1
- NIBUT < 12 seconds: Provides excellent diagnostic accuracy (sensitivity 90.2%, specificity 88.5%) for distinguishing dry eye from healthy subjects 1
- NIBUT ≤ 5 seconds: Indicates severe tear film instability 8
- For subtyping: NIBUT < 7.2 seconds may help differentiate evaporative from mixed dry eye subtypes 4
The 2024 Dry Eye Syndrome Preferred Practice Pattern guideline notes that "a rapid tear break-up time may indicate an unstable tear film with normal aqueous tear production" 6, emphasizing that NIBUT specifically assesses evaporative dysfunction rather than aqueous deficiency.
Management of Reduced NIBUT
When NIBUT is reduced, management should target the underlying cause of tear film instability:
Step 1: Identify the Subtype
Examine the meibomian glands and lid margins 6:
- Assess meibomian gland orifice patency and expressibility
- Look for lid margin abnormalities (vascularization, keratinization, hyperemia)
- Evaluate meibum quality (turbid, thickened, foamy, or deficient)
- Check for blepharitis signs (collarettes, deposits on lashes)
Step 2: Targeted Treatment Based on Findings
For meibomian gland dysfunction (most common with reduced NIBUT):
- Warm compresses to liquefy meibum
- Lid hygiene to address blepharitis
- In-office meibomian gland expression
- Consider intense pulsed light or thermal pulsation devices for severe cases
For evaporative dry eye without obvious MGD:
- Lipid-containing artificial tears or ointments
- Environmental modifications (humidifiers, reduce air flow exposure)
- Reduce screen time or implement 20-20-20 rule
For mixed presentation (reduced NIBUT plus aqueous deficiency signs):
- Combine lipid supplementation with aqueous tear supplementation
- Consider punctal plugs if Schirmer test also abnormal (< 5.5 mm without anesthesia) 6
- Anti-inflammatory therapy if signs of ocular surface inflammation present
Step 3: Monitor Response
Repeat NIBUT measurements are reliable for tracking treatment response, as the test shows good repeatability across sessions 3. Use the same instrument for serial measurements when possible.
Important Clinical Caveats
NIBUT correlates poorly with patient symptoms in mild to moderate disease 9. Only patients with severe OSDI scores show meaningful correlation with NIBUT values. Therefore, do not rely on NIBUT alone—it must be integrated with symptom assessment and other objective signs (ocular surface staining, Schirmer testing, meibomian gland evaluation) 6, 9.
The guideline explicitly states that diagnostic testing should include "tear break-up time, ocular surface dye staining, meibomian gland expressibility" as part of a comprehensive workup 6, not NIBUT in isolation.
Age considerations: NIBUT increases during middle childhood (ages 6-11), so interpret values in context of age-appropriate norms 8.